With high mortality rates observed in myeloma patients with coronavirus disease 2019 (COVID-19) coupled with the expected poor response to COVID-19 vaccinations, isolation periods are anticipated to increase, which will have a detrimental effect on the care of myeloma patients. Since the beginning of the COVID-19 pandemic, myeloma patients have been shielding, which has disrupted their therapy and healthcare provision, caused significant social isolation, and worsened mental health issues.
